<DOC>
	<DOCNO>NCT01780272</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate impact low blood sugar night sleep subject type 2 diabetes .</brief_summary>
	<brief_title>A Trial Investigate Impact Nocturnal Hypoglycaemia Sleep Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>Type 2 diabetes mellitus ( diagnose clinically ) least 24 week prior screen Currently treat antidiabetic treatment ( incl . diet exercise ) except insulin stable dose 4 week prior screen Body mass index 35 kg/m^2 Severe hypoglycaemic event past 6 month hospitalisation diabetic ketoacidosis previous 6 month Any chronic disorder severe disease clinical information ( include chronic obstructive pulmonary disease ( COPD ) , sleep apnoea epilepsy ) , opinion investigator might jeopardise subject 's sleep , safety compliance protocol , subject mental incapacity language barrier preclude adequate understanding cooperation , opinion investigator , participate trial Use antidepressant , antipsychotic , hypnotic , sedative drug know influence sleep within 12 week prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>